These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1782305)

  • 1. Effects of ranitidine, given t.d.s., on intragastric and oesophageal pH in patients with gastrooesophageal reflux.
    Russell J; Orr WC; Wilson T; Finn AL
    Aliment Pharmacol Ther; 1991 Dec; 5(6):621-30. PubMed ID: 1782305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-ranging study of ranitidine and its effect on intragastric and intra-oesophageal acidity in subjects with gastro-oesophageal reflux disease.
    Thomson AB; Babiuk L; Kirdeikis P; Zuk L; Marriage B; Bowes K
    Aliment Pharmacol Ther; 1994 Aug; 8(4):443-51. PubMed ID: 7986969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide.
    Orr WC; Finn A; Wilson T; Russell J
    Am J Gastroenterol; 1990 Jun; 85(6):697-700. PubMed ID: 2191595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo.
    Galmiche JP; Shi G; Simon B; Casset-Semanza F; Slama A
    Aliment Pharmacol Ther; 1998 Sep; 12(9):909-17. PubMed ID: 9768535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn.
    Miner P; Delemos B; Xiang J; Lococo J; Ieni J
    Aliment Pharmacol Ther; 2010 May; 31(9):991-1000. PubMed ID: 20132153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux.
    Orenstein SR; Blumer JL; Faessel HM; McGuire JA; Fung K; Li BU; Lavine JE; Grunow JE; Treem WR; Ciociola AA
    Aliment Pharmacol Ther; 2002 May; 16(5):899-907. PubMed ID: 11966498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
    Pipkin GA; Mills JG
    Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different doses of omeprazole on 24-hour oesophageal acid exposure in patients with gastro-oesophageal reflux.
    Robinson M; Maton PN; Allen ML; Humphries TJ; McIntosh D; Cagliola AJ; Bradstreet TE
    Aliment Pharmacol Ther; 1991 Dec; 5(6):645-51. PubMed ID: 1782307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
    Hatlebakk JG; Berstad A
    Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn.
    Robinson M; Rodriguez-Stanley S; Ciociola AA; Filinto J; Zubaidi S; Miner PB; Gardner JD
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1365-74. PubMed ID: 11552907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
    Smout AJ; Geus WP; Mulder PG; Stockbrügger RW; Lamers CB
    Scand J Gastroenterol Suppl; 1996; 218():10-5. PubMed ID: 8865445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
    Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
    BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine, cimetidine, antacids, and gastro-oesophageal reflux: results of a 20-hour oesophageal pH study.
    Desechalliers JP; Galmiche JP; Touchais JY; Denis P; Colin R
    Int J Clin Pharmacol Res; 1984; 4(3):217-22. PubMed ID: 6092288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
    Dettmar PW; Sykes J; Little SL; Bryan J
    Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
    Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R
    Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
    Bruley des Varannes S; Duquesnoy C; Mamet JP; Slama A; Galmiche JP; Scarpignato C
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
    Salvatore S; Hauser B; Salvatoni A; Vandenplas Y
    Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression.
    Orr WC; Harnish MJ
    Aliment Pharmacol Ther; 1998 Oct; 12(10):1033-8. PubMed ID: 9798810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.